Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.

Cisplatin (Cpt) is known to induce a high level of oxidative stress, resulting in an increase of reactive oxygen species damaging the inner ear and causing hearing loss at high frequencies. Studies on animal models show that antioxidants may lower Cpt-induced ototoxicity. The aim of this study is to...

Full description

Bibliographic Details
Main Authors: Laura Astolfi, Edi Simoni, Filippo Valente, Sara Ghiselli, Stavros Hatzopoulos, Milvia Chicca, Alessandro Martini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5025172?pdf=render
_version_ 1811324233812279296
author Laura Astolfi
Edi Simoni
Filippo Valente
Sara Ghiselli
Stavros Hatzopoulos
Milvia Chicca
Alessandro Martini
author_facet Laura Astolfi
Edi Simoni
Filippo Valente
Sara Ghiselli
Stavros Hatzopoulos
Milvia Chicca
Alessandro Martini
author_sort Laura Astolfi
collection DOAJ
description Cisplatin (Cpt) is known to induce a high level of oxidative stress, resulting in an increase of reactive oxygen species damaging the inner ear and causing hearing loss at high frequencies. Studies on animal models show that antioxidants may lower Cpt-induced ototoxicity. The aim of this study is to evaluate the ototoxic effects of two different protocols of Cpt administration in a Sprague-Dawley rat model, and to test in the same model the synergic protective effects of a solution of coenzyme Q10 terclatrate and Acuval 400®, a multivitamin supplement containing antioxidant agents and minerals (Acu-Qter). The Cpt was administered intraperitoneally in a single dose (14 mg/kg) or in three daily doses (4.6 mg/kg/day) to rats orally treated or untreated with Acu-Qter for 5 days. The auditory function was assessed by measuring auditory brainstem responses from 2 to 32 kHz at day 0 and 5 days after treatment. Similar hearing threshold and body weight alterations were observed in both Cpt administration protocols, but mortality reduced to zero when Cpt was administered in three daily doses. The Acu-Qter treatment was able to prevent and completely neutralize ototoxicity in rats treated with three daily Cpt doses, supporting the synergic protective effects of coenzyme Q terclatrate and Acuval 400® against Cpt-induced oxidative stress. The administration protocol involving three Cpt doses is more similar to common human chemotherapy protocols, therefore it appears more useful for long-term preclinical studies on ototoxicity prevention.
first_indexed 2024-04-13T14:10:43Z
format Article
id doaj.art-2c9d2ed370ed41c594eaff3e4025fa50
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T14:10:43Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2c9d2ed370ed41c594eaff3e4025fa502022-12-22T02:43:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016210610.1371/journal.pone.0162106Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.Laura AstolfiEdi SimoniFilippo ValenteSara GhiselliStavros HatzopoulosMilvia ChiccaAlessandro MartiniCisplatin (Cpt) is known to induce a high level of oxidative stress, resulting in an increase of reactive oxygen species damaging the inner ear and causing hearing loss at high frequencies. Studies on animal models show that antioxidants may lower Cpt-induced ototoxicity. The aim of this study is to evaluate the ototoxic effects of two different protocols of Cpt administration in a Sprague-Dawley rat model, and to test in the same model the synergic protective effects of a solution of coenzyme Q10 terclatrate and Acuval 400®, a multivitamin supplement containing antioxidant agents and minerals (Acu-Qter). The Cpt was administered intraperitoneally in a single dose (14 mg/kg) or in three daily doses (4.6 mg/kg/day) to rats orally treated or untreated with Acu-Qter for 5 days. The auditory function was assessed by measuring auditory brainstem responses from 2 to 32 kHz at day 0 and 5 days after treatment. Similar hearing threshold and body weight alterations were observed in both Cpt administration protocols, but mortality reduced to zero when Cpt was administered in three daily doses. The Acu-Qter treatment was able to prevent and completely neutralize ototoxicity in rats treated with three daily Cpt doses, supporting the synergic protective effects of coenzyme Q terclatrate and Acuval 400® against Cpt-induced oxidative stress. The administration protocol involving three Cpt doses is more similar to common human chemotherapy protocols, therefore it appears more useful for long-term preclinical studies on ototoxicity prevention.http://europepmc.org/articles/PMC5025172?pdf=render
spellingShingle Laura Astolfi
Edi Simoni
Filippo Valente
Sara Ghiselli
Stavros Hatzopoulos
Milvia Chicca
Alessandro Martini
Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.
PLoS ONE
title Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.
title_full Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.
title_fullStr Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.
title_full_unstemmed Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.
title_short Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.
title_sort coenzyme q10 plus multivitamin treatment prevents cisplatin ototoxicity in rats
url http://europepmc.org/articles/PMC5025172?pdf=render
work_keys_str_mv AT lauraastolfi coenzymeq10plusmultivitamintreatmentpreventscisplatinototoxicityinrats
AT edisimoni coenzymeq10plusmultivitamintreatmentpreventscisplatinototoxicityinrats
AT filippovalente coenzymeq10plusmultivitamintreatmentpreventscisplatinototoxicityinrats
AT saraghiselli coenzymeq10plusmultivitamintreatmentpreventscisplatinototoxicityinrats
AT stavroshatzopoulos coenzymeq10plusmultivitamintreatmentpreventscisplatinototoxicityinrats
AT milviachicca coenzymeq10plusmultivitamintreatmentpreventscisplatinototoxicityinrats
AT alessandromartini coenzymeq10plusmultivitamintreatmentpreventscisplatinototoxicityinrats